Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trial.

BMC Med · 2020 · PMC7534164 · PMID 33012286

Europe PMC DOI

hedged sentence

0.0960

closest p · 1.9× alpha

0.0960

boldest claim

The sentences

approached but did not reach significanceP = 0.096so close (0.05 < p ≤ 0.1)

Apatinib exposure was higher among patients with high IMAT than among patients with low IMAT, and the difference approached but did not reach significance ( P = 0.096, Table 1 ).

also in 210 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.